发明名称 |
METHODS FOR TREATING AT LEAST ONE CONDITION HAVING MT1 RECEPTOR, 5HT2B RECEPTOR, AND L-TYPE CALCIUM CHANNEL ACTIVITY |
摘要 |
The present invention is directed to methods comprising administering a composition comprising a therapeutically effective amount of (R)-verapamil, a derivative thereof, or a pharmaceutically acceptable salt thereof, wherein the composition treats, prevents and/or manages at least one condition having MT1 receptor, 5-HT2B receptor and L-type calcium channel activity and releases the (R)-verapamil, a derivative thereof or a pharmaceutically acceptable salt thereof to exhibit a co-primary activity on the MT1 receptor, the 5-HT2B receptor, and the L- type calcium channel. |
申请公布号 |
WO2008029300(A3) |
申请公布日期 |
2008.10.23 |
申请号 |
WO2007IB04185 |
申请日期 |
2007.07.18 |
申请人 |
AGI THERAPEUTICS RESEARCH LIMITED;DEVANE, JOHN;KELLY, JOHN;MARTIN, MARY |
发明人 |
DEVANE, JOHN;KELLY, JOHN;MARTIN, MARY |
分类号 |
A61P25/06;A61K31/277 |
主分类号 |
A61P25/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|